Expression of TAG-72 in ovarian cancer and its correlation with tumor stage and patient prognosis
- 8 January 2007
- journal article
- Published by Elsevier BV in Cancer Letters
- Vol. 251 (2), 247-257
- https://doi.org/10.1016/j.canlet.2006.11.025
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- The Correlation Between Cytoplasmic Overexpression of Epidermal Growth Factor Receptor and Tumor AggressivenessPancreas, 2004
- Progress and Challenges in Screening for Early Detection of Ovarian CancerMolecular & Cellular Proteomics, 2004
- Chemotherapy Tolerance After Radioimmunotherapy with90Y-CC49 Monoclonal Antibody in Patients with Advanced Non-Small Cell Lung Cancer: Clinical Effects and Hematologic ToxicityCancer Biotherapy & Radiopharmaceuticals, 2003
- Status of Tumor Markers in Ovarian Cancer ScreeningJournal of Clinical Oncology, 2003
- The contribution of tandem repeat number to the O-glycosylation of mucinsGlycobiology, 2002
- Ovarian Surface Epithelium: Biology, Endocrinology, and PathologyEndocrine Reviews, 2001
- Intraperitoneal Radioimmunotherapy of Ovarian Cancer with177Lu-CC49: A Phase I/II StudyGynecologic Oncology, 1997
- A B72.3 Second-Generation-Monoclonal Antibody (CC49) Defines the Mucin-Carried Carbohydrate Epitope Galβ(1—3) [NeuAcα(2—6)]GalNAcBiological Chemistry Hoppe-Seyler, 1989
- Monoclonal Antibody B72.3 Reactivity with Human EndometriumInternational Journal of Gynecological Pathology, 1987